Article

EyeCare America receives $1.125 million grant

San Francisco-EyeCare America, the public service program of the Foundation of the American Academy of Ophthalmology (FAAO), received a $1.125 million grant from Alcon Laboratories Inc., Fort Worth, TX.

San Francisco-EyeCare America, the public service program of the Foundation of the American Academy of Ophthalmology (FAAO), received a $1.125 million grant from Alcon Laboratories Inc., Fort Worth, TX.

The 5-year unrestricted grant will support EyeCare America's Senior EyeCare program, which bridges the health-care gap for an aging U.S. population. Through the program those who are eligible receive a dilated medical examination and up to 1 year of treatment at no out-of-pocket cost.

Today, more than two-thirds of visually impaired adults in the United States are over 65 years of age. The prevalence of blindness increases rapidly in the later years, particularly after age 75. The number of Americans with age-related eye disease is expected to double within the next 3 decades unless something is done to reverse the trend.

"Alcon is delighted to support this most worthwhile program," said Cary Rayment, Alcon's president and chief executive officer. "As a company, we have a commitment to give back to the community, and partnering with the Seniors EyeCare Program is an excellent way to fulfill that commitment."

To determine if a person qualifies for a referral, call the toll-free helpline 800/ 222-EYES (3937), which is available 24 hours a day, every day throughout the year.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
© 2025 MJH Life Sciences

All rights reserved.